A recent meta-analysis reviewed a total of 32 clinical studies involving 3,763 patients and confirmed that coenzyme Q10, a powerful antioxidant, may offer remarkable benefits in the treatment of heart failure. The analysis, which was published in the BMC Cardiovascular Disorders journal by researchers from China, included randomized controlled trials from Europe, Asia, Australia, and America. The findings emphatically demonstrate that coenzyme Q10 can improve heart health and boost exercise capacity in heart failure patients, as well as reduce hospitalization and mortality rates.
Today, we know that even without changing the letters in our DNA sequence, everyday foods - things like vitamins, minerals, or plant active compounds - can send signals that “talk” to cellular biological switches to modify gene expression. That affects everything from how we process our medications to how likely we are to develop diseases.
Widely circulating opinions—especially among the medical community—link vitamin C intake to an increased risk of kidney stones. This belief appears to stem from the interpretation of vitamin C metabolism, which includes the formation of oxalate, a compound found in kidney stone crystals. However, kidney stone formation is a complex process, and some studies even suggest that moderate dietary intake of vitamin C may be associated with a reduced risk of kidney stones. Individual factors—such as diet, genetics, and underlying health conditions—can influence the risk of developing kidney stones.
